These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10528070)

  • 1. Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles.
    Partidos CD; Vohra P; Jones DH; Farrar G; Steward MW
    J Control Release; 1999 Dec; 62(3):325-32. PubMed ID: 10528070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunization with a measles virus CTL epitope encapsulated in biodegradable PLG microparticles.
    Partidos CD; Vohra P; Jones DH; Farrar GH; Steward MW
    J Immunol Methods; 1996 Sep; 195(1-2):135-8. PubMed ID: 8814328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles.
    Partidos CD; Vohra P; Jones D; Farrar G; Steward MW
    J Immunol Methods; 1997 Aug; 206(1-2):143-51. PubMed ID: 9328577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes.
    Partidos CD; Vohra P; Anagnostopoulou C; Jones DH; Farrar GH; Steward MW
    Mol Immunol; 1996 Apr; 33(6):485-91. PubMed ID: 8700164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
    Partidos CD; Vohra P; Steward MW
    Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.
    Partidos CD; Vohra P; Steward MW
    Immunology; 1996 Feb; 87(2):179-85. PubMed ID: 8698377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
    Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements for synthetic immunogens to induce measles virus specific CTL responses.
    Partidos CD; Delmas A; Steward MW
    Mol Immunol; 1996 Nov; 33(16):1223-9. PubMed ID: 9129158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTL epitopes identified with a defective recombinant adenovirus expressing measles virus nucleoprotein and evaluation of their protective capacity in mice.
    Schadeck EB; Partidos CD; Fooks AR; Obeid OE; Wilkinson GW; Stephenson JR; Steward MW
    Virus Res; 1999 Dec; 65(1):75-86. PubMed ID: 10564754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
    Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ
    J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses.
    Sharpe S; Fooks A; Lee J; Hayes K; Clegg C; Cranage M
    Virology; 2002 Feb; 293(2):210-6. PubMed ID: 11886240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization.
    Hsu SC; Schadeck EB; Delmas A; Shaw M; Steward MW
    Vaccine; 1996 Aug; 14(12):1159-66. PubMed ID: 8911014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotype-specific and canine distemper virus cross-reactive H-2Kk-restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein.
    Beauverger P; Chadwick J; Buckland R; Wild TF
    Virology; 1994 Aug; 203(1):172-7. PubMed ID: 7518168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, physiochemical characterization, and oral immunogenicity of Abeta(1-12), Abeta(29-40), and Abeta(1-42) loaded PLG microparticles formulations.
    Rajkannan R; Arul V; Malar EJ; Jayakumar R
    J Pharm Sci; 2009 Jun; 98(6):2027-39. PubMed ID: 18980172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microparticles for intranasal immunization.
    Vajdy M; O'Hagan DT
    Adv Drug Deliv Rev; 2001 Sep; 51(1-3):127-41. PubMed ID: 11516784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes.
    Fomsgaard A; Nielsen HV; Kirkby N; Bryder K; Corbet S; Nielsen C; Hinkula J; Buus S
    Vaccine; 1999 Nov; 18(7-8):681-91. PubMed ID: 10547428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.
    Moureau C; Vidal PL; Bennasser Y; Moynier M; Nicaise Y; Aussillous M; Barthelemy S; Montagnier L; Bahraoui E
    Mol Immunol; 2002 Jan; 38(8):607-18. PubMed ID: 11792429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides.
    Sauzet JP; Gras-Masse H; Guillet JG; Gomard E
    Int Immunol; 1996 Apr; 8(4):457-65. PubMed ID: 8671632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.
    Oseroff C; Sette A; Wentworth P; Celis E; Maewal A; Dahlberg C; Fikes J; Kubo RT; Chesnut RW; Grey HM; Alexander J
    Vaccine; 1998 May; 16(8):823-33. PubMed ID: 9627940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation.
    Babu JS; Nair S; Kanda P; Rouse BT
    Vaccine; 1995 Dec; 13(17):1669-76. PubMed ID: 8719518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.